1H25 业绩符合我们预期爱康医疗公布1H25 业绩：收入6.94 亿元，同比增长5.7%；归母净利润1.61 亿元，同比增长15.3%，对应摊薄每股盈利0.14 元；业绩符合我们预期。发展趋势1H25 主营业务保持增长，海外销售增长下半年有望提速。1H25 公司业绩小幅增长，保持行业领先地位：髋关节业务营业收入达4.1 亿元，同比增长14%，维持了去年下半年的较高增速；膝关节业务营业收入约...
Source Link1H25 业绩符合我们预期爱康医疗公布1H25 业绩：收入6.94 亿元，同比增长5.7%；归母净利润1.61 亿元，同比增长15.3%，对应摊薄每股盈利0.14 元；业绩符合我们预期。发展趋势1H25 主营业务保持增长，海外销售增长下半年有望提速。1H25 公司业绩小幅增长，保持行业领先地位：髋关节业务营业收入达4.1 亿元，同比增长14%，维持了去年下半年的较高增速；膝关节业务营业收入约...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.